Life Sciences and Healthcare
Pharma competitive intelligence to track every pipeline move
Quickly monitor competitor pipelines, forecast launches, and spot early‑stage assets with expert-curated intelligence
- Analyze competitors by mechanism, indication, modality or technology- supported by 1,400+ drug-level SWOT analyses for deeper strategic insight.
- Get high-impact intelligence delivered straight to your inbox, tailored to your priorities, so you enver miss a critical update.
- Filter by 20+ attributes to quickly surface insights on specific drugs, therapies, and targets across your therapeutic areas.
- Access unmatched early-phase data to spot emerging competitor programs and investment opportunities first.
Request more information
Inform your strategy with a single source of truth
With Cortellis Competitive Intelligence, you can track 100K+ drugs and 283K+ companies across the global pharmaceutical landscape. Benchmark competitors by mechanism, indication, or expertly-curated intelligence with daily updates.
Understand the complete drug pipeline
Track competitors in your therapeutic area with pipeline intelligence across the full development lifecycle—from discovery to product launch.
Forecast launches with proven predictive analytics
Predict the timing and success of competing drug launches using Drug Timeline & Success Rates, powered by machine learning and 20+ years of Cortellis data.
Make confident portfolio and BD decisions
Validate investments with comprehensive clinical, deals, regulatory, and patent insights, to help de‑risk decisions and prioritize high‑potential opportunities.
FAQs
Cortellis Competitive Intelligence delivers the most comprehensive and deeply curated pipeline and competitor data, covering over 100,000 pipeline drugs, 3,000+ diseases, and millions of patents globally. Unlike general-purpose tools, it combines expert curation to provide accurate, secure, and actionable insights.
Advanced analytics like Drug Timeline & Success Rates offer predictive power that’s 35% more accurate than traditional benchmarks, helping you forecast success and launch timelines with confidence.
Integrated access to regulatory, clinical, discovery, deals, and generics intelligence in one platform saves time and enables faster, data-driven decisions.
Cortellis Competitive Intelligence is designed for competitive intelligence, portfolio strategy, and business development teams who need a complete, trusted view of the global drug pipeline. It is also widely used by R&D strategy, licensing and alliances, commercial planning, and market insights teams to monitor competitor programs, assess threats and opportunities, and support evidence-based strategic decisions across the product lifecycle.
Cortellis Competitive Intelligence supports high-impact decisions such as prioritizing therapeutic areas, evaluating in‑licensing or partnering opportunities, and identifying high‑potential early‑stage assets. It also helps teams plan for competitor launches, optimize portfolio and resource allocation, and build more accurate forecasts by grounding strategy in comprehensive, curated pipeline, clinical, regulatory, deal, and patent intelligence.
Yes, you can leverage bulk data from this competitive intelligence database as a data feed or API to power internal data and analytics solutions.